Medical Developments International (ASX:MVP) has been granted an ASX trading halt in relation to finalisation of a significant European licensing deal.
The halt will last until the earlier of the announcement being made or the start of trade on Monday, 29th June 2015.
The company manufactures Penthrox® a fast onset, non-opioid analgesic for trauma and emergency pain relief.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.
Medical Developments International (ASX:MVP) has been granted an...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.025(3.70%) |
Mkt cap ! $78.86M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 72.5¢ | 67.5¢ | $299.8K | 431.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 311 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| MVP (ASX) Chart |